Information only · not medical advice · nothing here is a recommendation · talk to a doctor
CRISPR gene editingAPPROVEDFACT
What it is A guided molecular cut-and-repair system. The first CRISPR therapy, for sickle-cell disease and beta-thalassaemia, was approved in late 2023 — blood stem cells are taken out, edited, and returned.
What to expect In those two diseases the results have been dramatic and, over the few years of follow-up so far, lasting. It is one edit, one tissue, one condition at a time; editing inside the body (for example the liver) is in trials, not yet routine.
The catch Off-target edits, delivery into the right tissue, and a price of about two million dollars per patient are the live problems. Using edited embryos to start a pregnancy is banned in most countries that regulate it, and no country explicitly allows it.
Evidence[17][18][19][20][21][22][23][24][25]
Gene therapyAPPROVEDFACT
What it is Delivering a working copy of a gene, usually inside a modified virus. Approved for spinal muscular atrophy, some inherited blindness, haemophilia and others.
What to expect For single-gene diseases with a known culprit, sometimes a one-off cure. For anything caused by hundreds of genes interacting, no.
Evidence[26]
Polygenic risk scoresMIXEDTHEORY
What it is Adding up thousands of small genetic effects to estimate your risk of a common condition.
What to expect Useful at population scale and for research. For one person they shift the odds modestly and are much less accurate outside the ancestry group they were trained on.
The catch Sold direct to consumers with more confidence than the numbers support.
Evidence[27][28][29]